(Q47975464)

English

A genetic polymorphism of matrix metalloproteinase 9 (MMP-9) affects the changes in circulating MMP-9 levels induced by highly active antiretroviral therapy in HIV patients

scientific article published on 21 April 2009

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

7 February 2018

http://europepmc.org/abstract/MED/19381161

A genetic polymorphism of matrix metalloproteinase 9 (MMP-9) affects the changes in circulating MMP-9 levels induced by highly active antiretroviral therapy in HIV patients (English)

1 reference

Europe PubMed Central

PubMed publication ID

7 February 2018

http://europepmc.org/abstract/MED/19381161

Alcyone Artioli Machado

5

1 reference

Europe PubMed Central

PubMed publication ID

7 February 2018

http://europepmc.org/abstract/MED/19381161

author name string

C Demacq

1

1 reference

Europe PubMed Central

PubMed publication ID

7 February 2018

http://europepmc.org/abstract/MED/19381161

V B Vasconcellos

2

1 reference

Europe PubMed Central

PubMed publication ID

7 February 2018

http://europepmc.org/abstract/MED/19381161

A M Marcaccini

3

1 reference

Europe PubMed Central

PubMed publication ID

7 February 2018

http://europepmc.org/abstract/MED/19381161

R F Gerlach

4

1 reference

Europe PubMed Central

PubMed publication ID

7 February 2018

http://europepmc.org/abstract/MED/19381161

J E Tanus-Santos

6

1 reference

Europe PubMed Central

PubMed publication ID

7 February 2018

http://europepmc.org/abstract/MED/19381161

publication date

21 April 2009

1 reference

Europe PubMed Central

PubMed publication ID

7 February 2018

http://europepmc.org/abstract/MED/19381161

The Pharmacogenomics Journal

1 reference

Europe PubMed Central

PubMed publication ID

7 February 2018

http://europepmc.org/abstract/MED/19381161

9

1 reference

Europe PubMed Central

PubMed publication ID

7 February 2018

http://europepmc.org/abstract/MED/19381161

4

1 reference

Europe PubMed Central

PubMed publication ID

7 February 2018

http://europepmc.org/abstract/MED/19381161

265-273

1 reference

Europe PubMed Central

PubMed publication ID

7 February 2018

http://europepmc.org/abstract/MED/19381161

Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2009.13

21 January 2018

Comparisons of causes of death and mortality rates among HIV-infected persons: analysis of the pre-, early, and late HAART (highly active antiretroviral therapy) eras

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2009.13

21 January 2018

HIV-associated lipodystrophy: pathogenesis, prognosis, treatment, and controversies

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2009.13

21 January 2018

Combination antiretroviral therapy and the risk of myocardial infarction

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2009.13

21 January 2018

Cardiovascular risk and body-fat abnormalities in HIV-infected adults

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2009.13

21 January 2018

State of the science conference: Initiative to decrease cardiovascular risk and increase quality of care for patients living with HIV/AIDS: executive summary

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2009.13

21 January 2018

Increased risk of myocardial infarction with duration of protease inhibitor therapy in HIV-infected men.

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2009.13

21 January 2018

Impact of dyslipidemia associated with Highly Active Antiretroviral Therapy (HAART) on cardiovascular risk and life expectancy

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2009.13

21 January 2018

Nucleoside reverse transcriptase inhibitors impair endothelium-dependent relaxation by increasing superoxide

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2009.13

21 January 2018

Plasma concentrations and genetic variation of matrix metalloproteinase 9 and prognosis of patients with cardiovascular disease

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2009.13

21 January 2018

Metalloproteinases 2 and 9 are increased in plasma of patients with heart failure

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2009.13

21 January 2018

Novel diagnostic test for acute stroke

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2009.13

21 January 2018

Future biomarkers for detection of ischemia and risk stratification in acute coronary syndrome

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2009.13

21 January 2018

Matrix metalloproteinases in the progression and regression of Kaposi's sarcoma

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2009.13

21 January 2018

Human immunodeficiency virus type-1 Nef protein induces blood-brain barrier disruption in the rat: role of matrix metalloproteinase-9.

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2009.13

21 January 2018

Cerebrospinal fluid levels of MMP-2, 7, and 9 are elevated in association with human immunodeficiency virus dementia

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2009.13

21 January 2018

Biochemistry and molecular biology of gelatinase B or matrix metalloproteinase-9 (MMP-9)

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2009.13

21 January 2018

Functional Polymorphism in the Regulatory Region of Gelatinase B Gene in Relation to Severity of Coronary Atherosclerosis

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2009.13

21 January 2018

Haplotypic analysis of the MMP-9 gene in relation to coronary artery disease

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2009.13

21 January 2018

Anti-HIV drugs decrease the expression of matrix metalloproteinases in astrocytes and microglia

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2009.13

21 January 2018

Circulating matrix metalloproteinase-9 is associated with cardiovascular risk factors in a middle-aged normal population

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2009.13

21 January 2018

Lercanidipine reduces matrix metalloproteinase-9 activity in patients with hypertension

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2009.13

21 January 2018

Definition and clinical importance of haplotypes

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2009.13

21 January 2018

The role of haplotypes in candidate gene studies

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2009.13

21 January 2018

Genetic polymorphism of matrix metalloproteinase (MMP)-9 does not affect plasma MMP-9 activity in healthy subjects.

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2009.13

21 January 2018

Effect of anticoagulants on the determination of plasma matrix metalloproteinase (MMP)-2 and MMP-9 activities

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2009.13

21 January 2018

Methodological issues affecting the determination of plasma matrix metalloproteinase (MMP)-2 and MMP-9 activities

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2009.13

21 January 2018

A New Statistical Method for Haplotype Reconstruction from Population Data

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2009.13

21 January 2018

Functional matrix metalloproteinase-9 polymorphism (C-1562T) associated with abdominal aortic aneurysm

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2009.13

21 January 2018

Polymorphisms in the promoter regions of MMP-2, MMP-3, MMP-9 and MMP-12 genes as determinants of aneurysmal coronary artery disease

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2009.13

21 January 2018

Protease inhibitors and cardiovascular outcomes in patients with HIV-1

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2009.13

21 January 2018

Antiretroviral therapy inhibits matrix metalloproteinase-9 from blood mononuclear cells of HIV-infected patients

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2009.13

21 January 2018

Haplotype tagging for the identification of common disease genes

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2009.13

21 January 2018

Identifiers

10.1038/TPJ.2009.13

1 reference

Europe PubMed Central

PubMed publication ID

7 February 2018

http://europepmc.org/abstract/MED/19381161

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

7 February 2018

http://europepmc.org/abstract/MED/19381161

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q47975464&oldid=2208990164"